Genoscience Pharma is proud that FDA granted an Orphan Drug Designation to GNS561 (a Genoscience’s innovation) for the treatment of Cholangiocarcinoma to GENFIT
You have a question ?
Genoscience Pharma is proud that FDA granted an Orphan Drug Designation to GNS561 (a Genoscience’s innovation) for the treatment of Cholangiocarcinoma to GENFIT
